While doctors understand that adolescents have certain unique health questions and concerns, several challenges prevent this critical information from being collected in a systematic way and providing appropriate referrals across a wide group of patients.
FDA’s top cancer leaders want to shift how companion diagnostics are regulated
The FDA is recognizing a major disconnect for some new cancer drugs. This idea that each new oncology drug approved is aligned at the time
July 13, 2023